rs150781290
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001367561.1(DOCK7):c.4073G>A(p.Arg1358Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000675 in 1,613,970 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. R1358R) has been classified as Likely benign.
Frequency
Consequence
NM_001367561.1 missense
Scores
Clinical Significance
Conservation
Publications
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 23Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| DOCK7 | NM_001367561.1 | c.4073G>A | p.Arg1358Gln | missense_variant | Exon 32 of 50 | ENST00000635253.2 | NP_001354490.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000854  AC: 13AN: 152158Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000717  AC: 18AN: 251192 AF XY:  0.0000442   show subpopulations 
GnomAD4 exome  AF:  0.0000657  AC: 96AN: 1461812Hom.:  1  Cov.: 32 AF XY:  0.0000564  AC XY: 41AN XY: 727204 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000854  AC: 13AN: 152158Hom.:  0  Cov.: 32 AF XY:  0.0000942  AC XY: 7AN XY: 74336 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 23    Uncertain:2 
- -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1358 of the DOCK7 protein (p.Arg1358Gln). This variant is present in population databases (rs150781290, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with DOCK7-related conditions. ClinVar contains an entry for this variant (Variation ID: 576166). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt DOCK7 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases    Uncertain:1 
The c.3980G>A (p.R1327Q) alteration is located in exon 31 (coding exon 31) of the DOCK7 gene. This alteration results from a G to A substitution at nucleotide position 3980, causing the arginine (R) at amino acid position 1327 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at